comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 17:27:48 - browse：341

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Will the FTC rein in IQVIA's health data empire?

entertainment

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

A new crop of companies is reshaping the health data economy

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Rise in cancer among younger people worries and puzzles doctors

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

What it's like to live with paralysis for one psychologist

entertainment

comprehensive

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Caribou posts encouraging results on off

Anesthesiologist group: stop taking Ozempic before surgery

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Anesthesiologist group: stop taking Ozempic before surgery

Former reverend arrested for allegedly killing 8

Malaria cases in Florida and Texas: Here’s what you need to know

Former reverend arrested for allegedly killing 8

Duchenne breakthrough therapy leaves behind pioneering families

What it's like to live with paralysis for one psychologist

explore

How a Boston hospital is priming medical residents to use GPT

STAT Report: Patient voices and perspectives

A new ‘biological computer' targets cancer while sparing healthy cells

How doctors’ personal politics affect patients

There’s a way to spot data fakery. All journals should be using it

Will the FTC rein in IQVIA's health data empire?

focus

entertainment

focus

leisure time